Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)ItalyStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
ItalyStudy Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer
ItalyStudy of Trastuzumab Deruxtecan and Rilvegostomig for Patients with Advanced HER2-positive Biliary Tract Cancer
ItalyStudy on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease
ItalyStudy on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17
ItalyStudy on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson's Disease
ItalyStudy Comparing Rinatabart Sesutecan with Other Treatments for Patients with Platinum-Resistant Ovarian Cancer
ItalyStudy on the Safety and Effects of BMS-986470 for Patients with Sickle Cell Disease
ItalyStudy of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations
ItalyStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
ItalyStudy of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
